Assignment history

Inventors

The named inventor for US patent 10448903 is Adam L. Kesner. At the time of filing, it is highly probable that Adam L. Kesner was employed by Memorial Sloan Kettering Cancer Center, as they are both the original and current assignee of the patent.

Original assignee

The entity named on the issued patent is Memorial Sloan Kettering Cancer Center. Their primary line of business is cancer treatment, research, and education. As a leading medical and research institution, Memorial Sloan Kettering Cancer Center likely implements the methods and systems described in the patent (e.g., for improved diagnostic imaging in oncology) within their clinical practice, thereby embodying the claims. They are an operating entity and are currently active.

Assignment timeline

• 2017-05-30 (executed) / recorded 2024-05-30 — Reel 067574/0953
  • Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST
  • Assignor: KESNER, ADAM L.
  • Assignee: MEMORIAL SLOAN KETTERING CANCER CENTER
  • Correspondent: MEMORIAL SLOAN KETTERING CANCER CENTER, OFFICE OF TECHNOLOGY DEVELOPMENT, 1275 YORK AVENUE, NEW YORK, NY 10065
  • Context: Inventor to original assignee transfer of interest in the invention.

The USPTO Assignment Center shows only one recorded assignment for US10448903, which is the assignment from the inventor to Memorial Sloan Kettering Cancer Center.

Timeline diagram

timeline
    title Ownership of US 10448903
    2007 : Priority date
    2017 : Inventor assigned rights to MSKCC
    2018 : Application filed
    2019 : Patent issued
    2024 : Assignment recorded

NPE / troll-pattern signals

1. Shell-entity transfer — Not present. The assignee, Memorial Sloan Kettering Cancer Center, is a well-known, operating medical and research institution, not a shell entity.
2. Known asserter in the chain — Not present. Memorial Sloan Kettering Cancer Center is not listed as a known patent asserter or NPE.
3. Repeat correspondent across the chain — Not present. Only one assignment is recorded (Reel 067574/0953), with Memorial Sloan Kettering Cancer Center's Office of Technology Development listed as the correspondent. There is no recurrence of this correspondent across a chain of transfers.
4. Cascading transfers — Not present. There is only one recorded assignment in the chain (Reel 067574/0953).
5. Pre-litigation transfer — Not present. No litigation has been identified for this patent, and the recorded assignment (executed 2017-05-30, recorded 2024-05-30, Reel 067574/0953) precedes the patent's issuance (2019-10-22) and is a transfer from the inventor to the initial assignee.
6. Bankruptcy fire-sale — Not present. Memorial Sloan Kettering Cancer Center is an active and operating institution.
7. Privateering — Not present. There is no evidence to suggest privateering, as the patent is held by a research institution rather than a typical operating company.
8. Defensive aggregator (anti-NPE) — Not present. The patent is currently assigned to Memorial Sloan Kettering Cancer Center, which is not a known defensive aggregator.

Verdict

Insufficient data. The sole recorded assignment for US10448903 is from the inventor, Adam L. Kesner, to Memorial Sloan Kettering Cancer Center (executed 2017-05-30, recorded 2024-05-30, Reel 067574/0953). This represents the initial transfer of rights from the inventor to his likely employer/institution, which is a standard patent prosecution practice. There are no subsequent transfers or any other signals indicating NPE activity.

USPTO Patent Assignment Search for US10448903